[Urgent Interview] The Blind Spot in the FY2026 Medical Fee Revision Threatening Regional Healthcare – Medical Tribune

News Highlights

Medical Tribune reports on the “blind spot” of the FY2026 medical fee revision and its impact on regional healthcare, based on an urgent interview with experts. The revision highlights the need for medium- to long-term management strategies, particularly for small and medium-sized medical institutions, that consider M&A and business succession, such as maintaining facility standards, distributing the burden of capital investment, and utilizing tax incentive schemes like transitioning to specific medical corporations or social medical corporations.

Perspective from the M&A Medical Editorial Department

The term “blind spot” in the FY2026 medical fee revision is presumed to be a warning of structural changes in regional healthcare, extending beyond mere fee increases or decreases. In particular, measures such as “securing the regional healthcare provision system” and “strengthening the role of primary care physicians,” which are key features of the revision, can become a financial burden for small and medium-sized hospitals and clinics that find it difficult to meet these requirements independently. For example, if facility functions of a certain scale or advanced capital investment are required, independent maintenance becomes difficult, making group affiliation for economies of scale and the distribution of expenses and capital investment burdens a realistic option. Furthermore, tax benefits through becoming a social medical corporation can be a powerful means to strengthen the management base while meeting the requirements for contributing to regional healthcare. This revision not only questions the sustainability of regional healthcare but also forces the consideration of more fundamental management restructuring, such as M&A and changes in corporate status.

Points Raised by This News

• The FY2026 revision is not merely a fee adjustment but the beginning of a structural change that promotes the rebuilding of the regional healthcare provision system.
• Small and medium-sized medical institutions may inevitably pursue economies of scale through group affiliation or M&A to maintain facility standards and distribute capital investment burdens.
• To balance contributions to regional healthcare with tax incentives, considering corporate status changes, including becoming a social medical corporation, is becoming increasingly important.
• The “blind spot” of the revision suggests the need for structural support measures for medical institutions facing a shortage of healthcare providers and declining financial strength.

Practical Questions Arising from This News

• With this revision, what facility standards must our hospital meet, and what functions are particularly required to be strengthened?
• When considering becoming a social medical corporation, what are the specific merits and demerits in terms of contribution to regional healthcare, profitability, and taxation?
• When considering group affiliation or M&A, what are the steps involved, and what scale of benefits can be expected?

If You Feel “Should I Consult?”

If you are a manager or successor who feels concerned by the term “blind spot” in the FY2026 medical fee revision, it is crucial to first grasp your institution’s current situation and the specific impact of the revision. In particular, if there are concerns about the strengthened regional healthcare provision system or increased burdens on small and medium-sized hospitals due to the revision, you must consider the possibility of difficulty in continuing operations independently. Starting discussions early with experts about options such as group affiliation, M&A, and changes in corporate status is key to protecting the sustainability of regional healthcare and the future of your institution.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, supporting the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultation here